en

PRODUCT DETAIL

Bydureon 2 mg prášok a disperzné prostredie na injekčnú suspenziu s predĺženým uvoľňovaním

Code 08673
MA number EU/1/11/696/002
Product Form: plu igf 3x(4x1) (2 mg práš.+0,65 ml disperz..prostr.- jednodávk.súprava)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 18 - ANTIDIABETICA (VRÁTANE INZULÍNU)
ATC:
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
A10BJ Glucagon-like peptide-1 receptor (GLP-1) analogues
A10BJ01 Exenatide
Shelf life: 36
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - known active substance
MA issued: 17.06.2011
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 10.10.2018
eu-flag.png sk-flag.png